154P Ocular toxicity related to mirvetuximab soravtansine in ovarian cancer: A real-world analysis
ESMO Open · 2026-07 · 11 · 108201
DOI: 10.1016/j.esmoop.2026.108201 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESMO Open, 2026-07. Verfasst von A. Giustozzi und 13 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Giustozzi, A., Dominicis, F. D., Salgarello, T., Cocuzza, M., Carbone, M., Boccia, S., Iacobelli, V., Perri, M., Sassu, C., Palma, A. D., Marchetti, C., Fagotti, A., Giudiceandrea, A., & Salutari, V. (2026). 154P Ocular toxicity related to mirvetuximab soravtansine in ovarian cancer: A real-world analysis. ESMO Open, 11, 108201. https://doi.org/10.1016/j.esmoop.2026.108201
Vancouver
Giustozzi A, Dominicis FD, Salgarello T, Cocuzza M, Carbone M, Boccia S, et al. 154P Ocular toxicity related to mirvetuximab soravtansine in ovarian cancer: A real-world analysis. ESMO Open. 2026;11:108201. doi:10.1016/j.esmoop.2026.108201
BibTeX
@article{Giustozzi2026,
author = {Giustozzi, A. and Dominicis, F. De and Salgarello, T. and Cocuzza, M. and Carbone, M.V. and Boccia, S.M. and Iacobelli, V. and Perri, M.T. and Sassu, C.M. and Palma, A. De and Marchetti, C. and Fagotti, A. and Giudiceandrea, A. and Salutari, V.},
title = {154P Ocular toxicity related to mirvetuximab soravtansine in ovarian cancer: A real-world analysis},
journal = {ESMO Open},
year = {2026},
volume = {11},
pages = {108201},
doi = {10.1016/j.esmoop.2026.108201}
}
EUVIMED